Skip to main content
CLNN logo

CLNN · Clene Inc. · Financials

Track CLNN — free
$3.91 -0.17 (-4.17%) At close · Oct 5
Market Cap
$55.25M
Shares
12.85M
Volume · Oct 5 278.24K Avg daily vol (3M) 99.28K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$200K -41.5%
FY2025 Revenue FY2020–FY2025
Net Income
-$26.17M +33.6%
FY2025 Net Income FY2019–FY2025
Gross Margin
78.5% -1pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-11541.5% -1865.2pp
FY2025 Operating Margin FY2020–FY2025
Operating Cash Flow
-$18.55M +13%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$197K $200K $342K $654K $473K $723K $206K —
— — — — -$3.3M -$870K — —
$59K $43K $70K $121K $26K $289K — —
$138K $157K $272K $533K $447K $434K — —
— 78.5% 79.53% 81.5% 94.5% 60.03% — —
$12.82M $14.01M $20.06M $26.66M $31.92M $28.42M $15.2M $9.56M
$7.87M $9.23M $13.31M $14.42M $16.94M $22M $5.15M $6.77M
$51.23M — — — — $50.7M $20.42M $16.33M
$20.75M $23.28M $33.44M $41.19M $48.88M $50.7M — —
-$20.55M -$23.08M -$33.09M -$40.54M -$48.41M -$49.98M -$20.21M -$16.33M
— -11541.5% -9676.32% -6198.78% -10234.46% -6912.59% -9812.62% —
$2.88M $2.68M $4.06M $4.56M $3.3M $870K $950K $88K
$182K $223K $865K $1.39M $225K — — —
-$18.97M -$3.09M -$6.31M -$8.96M $18.49M $39.81M $1.34M $177K
-$39.52M -$26.17M -$39.4M -$49.5M -$29.92M -$10.17M -$18.87M -$16.16M
$0 $0 $0 $0 $0 -$428K $406K —
-$39.52M -$26.17M -$39.4M -$49.5M -$29.92M -$9.74M -$19.28M -$16.16M
— -13086.5% -11520.47% -7569.42% -6325.16% -1347.16% -9357.77% —
-$39.46M -$26.07M -$39.53M -$49.51M -$29.95M -$9.83M -$18.99M -$16.16M
USD/shares -$3.55 -$2.65 -$5.67 -$9.43 -$9.20 -$3.20 — —
shares — 9.86M 6.95M 5.25M 3.26M 3.08M 875.2K 867.88K
shares — — — — — 3.08M 875.2K 867.88K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2026-06-30 USD 17,604,000 10-Q filed 2026-08-14
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of convertible notes payable
USD 0
Noncurrent notes payable
USD 5,374,000
Operating lease liabilities 2026-06-30 USD 3,620,000 10-Q filed 2026-08-14
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 815,000
Noncurrent operating lease liabilities
USD 2,805,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
320.72×
Peer median 0.90×
EV/EBIT
—
P/E (TTM)
—
Peer median 15.65×

Peer medians compare against the 28 similar-size Packaged Foods companies (of 73 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2022 FY2021
Supplements Segment $473,000 $723,000
Drugs Segment $0 $0

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Product $119,000 $237,000 $498,000 $329,000 $570,000 $176,000
Royalty $81,000 $105,000 $156,000 $144,000 $153,000 $30,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2022 FY2021
Supplements Segment $360,000 $205,000
Drugs Segment -$48,769,000 -$50,183,000

Operating Margin by Segment (%)

Component FY2022 FY2021
Supplements Segment 76.1% 28.4%
Key facts CIK 1822791 CUSIP 185634201 13F (30d) 1 filings 1 filers Visit website Investor relations